Results 341 to 350 of about 204,699 (375)
Some of the next articles are maybe not open access.

Idiopathic pulmonary fibrosis

Current Opinion in Pulmonary Medicine, 1996
Idiopathic pulmonary fibrosis (IPF), or cryptogenic fibrosing alveolitis as it is known in the United Kingdom and Europe, is perhaps one of the most complex and frustrating pulmonary disorders. The cause of this illness is unknown. Treatment often founders in a mire of discontent, dissatisfaction, and failure. In fact, the philosophic homily "If you do
openaire   +3 more sources

Familial Idiopathic Pulmonary Fibrosis

2013
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease of unknown etiology, with an appearance of usual interstitial pneumonia on lung biopsy. To-date, about a 100 families diagnosed with IPF have been described. Familial IPF is defined as histologically confirmed IPF occurring in two or more members of a family.
K. Wytrychowski   +2 more
openaire   +3 more sources

Fibrose pulmonaire idiopathique

La Presse Médicale, 2008
Idiopathic pulmonary fibrosis is a chronic disorder characterized histopathologically by a pattern of usual interstitial pneumonia, with heterogeneous and mutilating interstitial fibrosis with foci of proliferating fibroblasts, honeycomb lung, and little if any inflammation.
Cottin, Vincent, Cordier, Jean-François
openaire   +5 more sources

Idiopathic Pulmonary Fibrosis

Archives of Internal Medicine, 1981
BETSY Harris, MD, Assistant Resident in Medicine, the Jewish Hospital of St Louis: A 49-year-old woman was admitted to the hospital with a five-day history of short-ness of breath. Two weeks before admission, a cough that produced "some whitish material" developed and an oral temperature of 37°C was recorded.
Betsy Harris   +2 more
openaire   +2 more sources

Idiopathic pulmonary fibrosis

Meditsinskaya sestra, 2021
Vsevolod V. Skvortsov   +4 more
openaire   +1 more source

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

American Journal of Respiratory and Critical Care Medicine, 2015
G. Raghu   +20 more
semanticscholar   +1 more source

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Yearbook of Pulmonary Disease, 2015
Tomohiro Handa, Arata Azuma
semanticscholar   +1 more source

Immune-checkpoint inhibitors: long-term implications of toxicity

Nature Reviews Clinical Oncology, 2022
Javid J Moslehi, Justin M Balko
exaly  

Home - About - Disclaimer - Privacy